Maintaining control: The rising challenges of clinical data management
June 18, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
From breach scandals to GDPR, data is becoming a more prominent part of our everyday lives. This holds great potential …
HPV vaccine slashes rate of infection by 86% in UK
June 18, 2018Medical Communications, Sales and Marketing HPV, biotech, drugs, pharma, pharmaceutical, vaccination
Since the introduction of the vaccination against the Human Papilloma Virus in 2008, there has been an 86% drop in …
Teva axes Phase 3 trial into chronic cluster headache
June 18, 2018Research and Development, Sales and Marketing Teva, fremanezumab, headache, pharma
With the advent of another week, there’s another trial discontinuation in the industry as Teva announces its decision to terminate …
BMS’ Opdivo becomes first immuno-oncology agent available in China
June 18, 2018Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, China, NSCLC, lung cancer, oncology, opdivo, pharma
Bristol-Myers Squibb’s flagship immunotherapy Opdivo (nivolumab) has broken ground to become the first and only PD-1 inhibitor to be made …
£20bn promised to NHS but questions over where money will come from
June 18, 2018Medical Communications, Sales and Marketing NHS, UK government, biotech, drugs, pharma, pharmaceutical
Theresa May finally attempted to tackle the elephant in the room for the UK government, well, the one other than …
Top Ten most popular articles on Pharmafile.com this week
June 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Another busy in week in pharma has seen a number of companies release promising data on their drugs, Roche’s study …
Allergan appoints ex-Abbott exec in “Board refreshment” move
June 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Allergan, appointment, pharma
Allergan has announced another move in its “refreshment” of its executive Board of Directors with the appointment of Thomas C …
New Jersey attempts to lure Teva HQ with tax incentives
June 15, 2018Medical Communications Teva, biotech, drugs, pharma, pharmaceutical
Teva has been doing some major global restructuring since Kare Schultz came to the helm of the embattled, Israeli drugmaker. …
NICE turns down Roche’s Perjeta for post-surgery HER2-positive breast cancer
June 15, 2018Medical Communications, Sales and Marketing Cancer, NICE, Perjeta, Roche, breast cancer, pharma
Roche’s ongoing dispute with UK health service watchdog NICE over the availability of its monoclonal antibody Perjeta (pertuzumab) on the …
Gene therapy offers hope for those with paralysis
June 15, 2018Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical
Researchers at King’s College London (KCL) have made significant progress to being able to offer a treatment to those with …
Living with childhood dementia
June 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing childhood dementia, dementia, feature, patient experience, pharma
Claire Young explores her family’s journey through the diagnosis of her son George, who lives with Batten disease, a form …
Roche’s Ocrevus extends time-to-wheelchair by 7 years in progressive MS patients
June 14, 2018Research and Development Ocrevus, Roche, multiple sclerosis, pharma
Roche has lifted the curtain on more promising data at Phase 3 for its humanised anti-CD20 monoclonal antibody Ocrevus (ocrelizumab), …
Danger of Sanofi’s dengue vaccine confirmed in new study
June 14, 2018Medical Communications, Research and Development Sanofi, biotech, dengue, dengvaxia, drugs, pharma, pharmaceutical
A study that thoroughly analyses the impact of Sanofi’s dengue vaccine has confirmed what was feared – children without prior …
FDA knocks back Mylan’s Advair generic for second time
June 14, 2018Sales and Marketing Advair, FDA, GSK, Mylan, pharma
The FDA has rejected Mylan’s generic version of GlaxoSmithKline’s Advair for the second time following its knockback last year, citing …
UK immigration rules to be waived to bring in more doctors
June 14, 2018Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
The NHS’ recruitment crisis has been on-going for a number of years, with an ageing population and a higher workload …
Report highlights that half of women in science face harassment
June 14, 2018Medical Communications biotech, drugs, pharma, pharmaceutical
Arriving at a particularly low point for the reputation of the biotech, after STAT revealed that a party at BIO …
UK demand for mental health apps soars 566% since 2014
June 13, 2018Medical Communications, Research and Development UK, apps, mental health, pharma
A new report from communications and research agencies GK Strategy and onefourzero has revealed the massive extent to which consumer …
Vaccination rates in parts of US fall to dangerous levels
June 13, 2018Research and Development anti-vax, biotech, drugs, pharma, pharmaceutical, vaccination
The anti-vaxxer movement is the scourge of meticulously researched science and yet, in certain states in the US, it seems …
Celgene showcases strong Otezla data in psoriatic arthritis
June 13, 2018Research and Development Celgene, EULAR, otezla, pharma
Celgene has seized the opportunity at the Annual European Congress of Rheumatology in Amsterdam to reveal positive new data for …
J&J continues to shed assets, with $2.1bn diabetes unit sale
June 13, 2018Research and Development, Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical
Just last week, Johnson & Johnson announced that it had received an offer from Fortive for its medical sterilisation unit, …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
